Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 6, 2009, Pages 613-619

  Tahara, Tomomitsu ^a   Arisawa, Tomiyasu ^a   Shibata, Tomoyuki ^a,b   Nakamura, Masakatsu ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Maruyama, Naoko ^a   Kamano, Toshiaki ^a   Kamiya, Yoshio ^a   Fujita, Hiroshi ^a   Nakagawa, Yoshihito ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Takahama, Kazuya ^a   Watanabe, Makoto ^a   Yamashita, Hiromi ^a   Hirata, Ichiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric mucosa; Gastritis; H. Pylori; Methylation

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DNA; PEPSINOGEN I; PEPSINOGEN II; PROTEIN P14; PROTEIN P16; UVOMORULIN;

ADULT; ARTICLE; ATROPHY; CELL INFILTRATION; CHRONIC GASTRITIS; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SEROLOGY; STOMACH ANTRUM;

AGED; CHRONIC DISEASE; CPG ISLANDS; DNA METHYLATION; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; PROMOTER REGIONS, GENETIC; SEVERITY OF ILLNESS INDEX;

EID: 67449134096     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830e28b2     Document Type: Article

References (21)

1. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Wat Gene. 1994; 7:536-540.
2. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Re. 1998; 58:5489-5494.
3. Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, et al. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Re. 2002; 62:1148-1151.
4. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age- related CpG island methylation in ulcerative colitis. Cancer Re. 2001; 61:3573-3577.
5. Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterolog. 2002; 122:1113-1121.
6. Wong DJ, Paulson TG, Prevo U, Galipeau PC, Longton G, Blount PL, et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Re. 2001; 61: 8284-8289.
7. Kaneto H, Sasaki S, Yamamoto H, Itoh F, Toyota M, Suzuki H, et al. Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gu. 2001; 48:372-377.
8. Chan AO, Urn SK, Wong BC, Wong WM, Yuen MF, Yeung YH, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylor. infection and in gastric cancer. Gu. 2003; 52:502-506.
9. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, et al. High levels of aberrant DNA methylation in Helicobacte. py/on'-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Re. 2006; 12:989-995.
10. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Patho. 2003; 163: 1551-1556.
11. Tahara T, Arisawa T, Shibata T, Wang FY, Nakamura M, Sakata M, et al. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestio. 2007; 75:54-61.
12. Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H. CpG island hypermethylation of tumor-suppressor genes in H. py/on'-infected nonneoplastic gastric mucosa is linked with gastric cancer risk. Helicobacte. 2008; 13:35-41.
13. Nakajima T, Maekita T, Oda I, Gotoda T, Yamamoto S, Umemura S, et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Pre. 2006; 15:2317-2321.
14. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Patho. 1996; 20:1161-1181.
15. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Re. 2000; 60:129-133.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation- specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci US. 1996; 93:9821-9826.
17. Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP- kinase CpG island is a common alteration in B-cell malignancies. Bloo. 1999; 93:4347-4353.
18. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylor. to serum pepsinogens in an asymptomatic Japanese population. Gastroenterolog. 1992; 102:760-766.
19. Kekki M, Samloff IM, Varis K, lhamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroentero. 1991; 186:S109-S116.
20. Correa P. Helicobacter pylor. and gastric carcinogenesis. Am J Surg Patho. 1995; 19 (Suppl 1):S37-S43.
21. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, ef al. Helicobacter pylor. infection and the development of gastric cancer. N Engl J Me. 2001; 345:784-789.